- Home
- CVKD vs GROW Comparison
CVKD vs GROW Comparison
Compare CVKD & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- GROW
- Stock Information
- Founded
- CVKD 2022
- GROW 1968
- Country
- CVKD United States
- GROW United States
- Employees
- CVKD N/A
- GROW N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- GROW Investment Managers
- Sector
- CVKD Health Care
- GROW Finance
- Exchange
- CVKD Nasdaq
- GROW Nasdaq
- Market Cap
- CVKD 29.5M
- GROW 32.2M
- IPO Year
- CVKD 2023
- GROW N/A
- Fundamental
- Price
- CVKD $12.80
- GROW $2.46
- Analyst Decision
- CVKD Strong Buy
- GROW
- Analyst Count
- CVKD 1
- GROW 0
- Target Price
- CVKD $32.00
- GROW N/A
- AVG Volume (30 Days)
- CVKD 34.6K
- GROW 20.3K
- Earning Date
- CVKD 08-11-2025
- GROW 09-12-2025
- Dividend Yield
- CVKD N/A
- GROW 3.70%
- EPS Growth
- CVKD N/A
- GROW N/A
- EPS
- CVKD N/A
- GROW 0.01
- Revenue
- CVKD N/A
- GROW $8,932,000.00
- Revenue This Year
- CVKD N/A
- GROW N/A
- Revenue Next Year
- CVKD N/A
- GROW N/A
- P/E Ratio
- CVKD N/A
- GROW $230.98
- Revenue Growth
- CVKD N/A
- GROW N/A
- 52 Week Low
- CVKD $6.89
- GROW $2.02
- 52 Week High
- CVKD $22.90
- GROW $2.68
- Technical
- Relative Strength Index (RSI)
- CVKD 53.26
- GROW 51.28
- Support Level
- CVKD $12.02
- GROW $2.39
- Resistance Level
- CVKD $14.10
- GROW $2.59
- Average True Range (ATR)
- CVKD 0.88
- GROW 0.07
- MACD
- CVKD 0.13
- GROW -0.00
- Stochastic Oscillator
- CVKD 63.38
- GROW 33.33
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.